Format

Send to

Choose Destination
See comment in PubMed Commons below
Clin Ther. 2012 Dec;34(12):2293-6. doi: 10.1016/j.clinthera.2012.10.008. Epub 2012 Nov 7.

A review investigating the effect of allopurinol on the progression of kidney disease in hyperuricemic patients with chronic kidney disease.

Abstract

This communication provides a brief report on the studies evaluating the use of allopurinol for delay of kidney disease progression and a discussion of the current limitations and future research needed. To date, only 5 studies have reported a delay in the progression of kidney disease with allopurinol use; a sixth study is currently underway. Allopurinol does seem to delay the progression of kidney disease as measured by using serum creatinine and glomerular filtration rates in hyperuricemic patients with chronic kidney disease. However, randomized, double-blind, placebo-controlled trials enrolling more patients and controlling for confounding variables are needed to confirm these findings.

PMID:
23140758
DOI:
10.1016/j.clinthera.2012.10.008
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center